Newsroom Stories

Researchers from WashU McKelvey Engineering have developed a hybrid system that augments organisms including locusts to serve as sample collectors for chemical vapors. The work has implications for homeland security, environmental and industrial monitoring and healthcare.

The Sam Fox School Gallery at Washington University in St. Louis presents “It Is What It Is When It Is,” a solo exhibition of new work from St. Louis-based artist Sterling Lawrence.

A dispute before the U.S. Supreme Court over the Video Privacy Protection Act could have significant implications for surveillance-based advertising and the future of internet privacy, says Neil Richards, a privacy law expert at Washington University in St. Louis.

A new study led by researchers at Olin Business School at Washington University in St. Louis finds private equity only accounts for a small share of the nation’s hospitals, with most investors exiting within five years.

A nationally recognized pediatric endocrinologist, Madhusmita Misra, MD, pioneered research on bone density and metabolic disorders in young women. Her appointment begins Jan. 4.

WashU will formally adopt the Okanagan Charter, reinforcing the university’s commitment to making health and well-being an integral part of campus culture and decision-making.

The United States imposed sweeping new sanctions against the International Criminal Court (ICC) Oct. 9, following up on sanctions imposed last year. They are threatening academic freedom, limiting opportunities for law students and making it harder for scholars to engage with international legal institutions, WashU law professor Leila Sadat argues.

A well-known clock gene helps plants sense salt and respond to it, according to new research from biologist Xuehua Zhong in WashU Arts & Sciences. The findings could help scientists develop more resilient crops.

Economist David Spielman brings global expertise in food policy and agricultural innovation to Bursky Public Health, advancing research connecting food systems and health.

The funding will support a WashU Medicine collaboration with CRISPR Therapeutics and SynGenix, a WashU startup, to move a single-injection treatment to reverse joint damage into clinical trials.